| Primary |
| Hypertension |
37.6% |
| Drug Use For Unknown Indication |
22.1% |
| Essential Hypertension |
8.6% |
| Diabetes Mellitus |
5.3% |
| Hiv Infection |
4.0% |
| Unevaluable Event |
2.3% |
| Arteriosclerosis |
2.0% |
| Hyperlipidaemia |
2.0% |
| Ischaemic Cardiomyopathy |
2.0% |
| Myocardial Ischaemia |
2.0% |
| Blood Pressure Management |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Infection |
1.3% |
| Myocardial Infarction |
1.3% |
| Polyuria |
1.3% |
| Reflux Oesophagitis |
1.3% |
| Diagnostic Procedure |
1.0% |
| Hepatitis C |
1.0% |
| Hyperuricaemia |
1.0% |
| Anxiety Disorder |
0.7% |
|
| Oedema Peripheral |
7.9% |
| Blood Pressure Increased |
6.3% |
| Hypotension |
6.3% |
| Liver Disorder |
6.3% |
| Neutropenia |
6.3% |
| Toxic Skin Eruption |
6.3% |
| Drug Ineffective |
4.8% |
| Fluid Retention |
4.8% |
| Hiatus Hernia |
4.8% |
| No Adverse Event |
4.8% |
| Pleural Effusion |
4.8% |
| Rash |
4.8% |
| Rash Pruritic |
4.8% |
| Sensory Integrative Dysfunction |
4.8% |
| Umbilical Cord Vascular Disorder |
4.8% |
| Weight Increased |
4.8% |
| Adverse Event |
3.2% |
| Adverse Reaction |
3.2% |
| Altered State Of Consciousness |
3.2% |
| Ascites |
3.2% |
|
| Secondary |
| Hypertension |
43.8% |
| Drug Use For Unknown Indication |
19.0% |
| Rheumatoid Arthritis |
6.9% |
| Essential Hypertension |
3.9% |
| Hyperuricaemia |
3.7% |
| Product Used For Unknown Indication |
3.4% |
| Diabetes Mellitus |
2.5% |
| Cerebral Infarction |
2.0% |
| Gastritis |
2.0% |
| Ischaemic Cardiomyopathy |
1.7% |
| Pulmonary Hypertension |
1.5% |
| Tuberculosis |
1.5% |
| Angina Pectoris |
1.2% |
| Back Pain |
1.0% |
| Bladder Obstruction |
1.0% |
| Blood Pressure Increased |
1.0% |
| Bronchitis Chronic |
1.0% |
| Carotid Artery Stenosis |
1.0% |
| Depression |
1.0% |
| Diagnostic Procedure |
1.0% |
|
| Tinnitus |
16.7% |
| Interstitial Lung Disease |
6.9% |
| Sepsis |
6.9% |
| Acute Myocardial Infarction |
5.6% |
| Prostatitis |
5.6% |
| Pyrexia |
5.6% |
| Rash Pruritic |
5.6% |
| Renal Impairment |
5.6% |
| Erythema |
4.2% |
| Hypertension |
4.2% |
| Platelet Count Decreased |
4.2% |
| Shock |
4.2% |
| Tremor |
4.2% |
| Weight Increased |
4.2% |
| Altered State Of Consciousness |
2.8% |
| Bicytopenia |
2.8% |
| Blood Pressure Decreased |
2.8% |
| Blood Pressure Inadequately Controlled |
2.8% |
| Blood Urea Increased |
2.8% |
| Cerebral Infarction |
2.8% |
|
| Concomitant |
| Hypertension |
40.7% |
| Product Used For Unknown Indication |
9.4% |
| Drug Use For Unknown Indication |
7.0% |
| Diabetes Mellitus |
4.9% |
| Hepatitis C |
4.2% |
| Prophylaxis |
4.1% |
| Rheumatoid Arthritis |
3.8% |
| Insomnia |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Constipation |
2.2% |
| Metastatic Renal Cell Carcinoma |
2.0% |
| Angina Pectoris |
1.9% |
| Hyperlipidaemia |
1.9% |
| Osteoporosis |
1.9% |
| Pain |
1.9% |
| Hyperuricaemia |
1.9% |
| Hyperphosphataemia |
1.7% |
| Hepatic Neoplasm Malignant |
1.6% |
| Gastritis |
1.5% |
| Renal Cell Carcinoma |
1.3% |
|
| Pyrexia |
9.1% |
| Renal Impairment |
8.6% |
| Vomiting |
7.1% |
| Renal Failure Acute |
5.8% |
| White Blood Cell Count Decreased |
5.8% |
| Death |
5.3% |
| Interstitial Lung Disease |
5.1% |
| Rash |
5.1% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
4.9% |
| Pneumonia |
4.7% |
| Rheumatoid Arthritis |
4.4% |
| Platelet Count Decreased |
4.2% |
| Weight Decreased |
4.0% |
| Cardiac Failure |
3.8% |
| Hyperkalaemia |
3.8% |
| Hypoglycaemia |
3.8% |
| Liver Disorder |
3.8% |
| Rhabdomyolysis |
3.8% |
| Anaemia |
3.5% |
| Renal Failure |
3.5% |
|
| Interacting |
| Hiv Infection |
33.3% |
| Hypertension |
25.0% |
| Myocardial Ischaemia |
20.0% |
| Diabetes Mellitus |
6.7% |
| Gastritis |
6.7% |
| Hyperlipidaemia |
6.7% |
| Angina Pectoris |
1.7% |
|
| Hypotension |
83.3% |
| Pyrexia |
16.7% |
|
